ZKSCAN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.84659995575254E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.176730E-04 |
Normal-vs-Stage2 |
9.14000000129533E-08 |
Normal-vs-Stage3 |
1.3627998729504E-10 |
Normal-vs-Stage4 |
1.21240018025048E-10 |
Stage1-vs-Stage2 |
1.182440E-02 |
Stage1-vs-Stage3 |
1.222070E-04 |
Stage1-vs-Stage4 |
2.025800E-04 |
Stage2-vs-Stage3 |
8.753600E-01 |
Stage2-vs-Stage4 |
5.298200E-01 |
Stage3-vs-Stage4 |
5.570400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.57789958455635E-10 |
Normal-vs-AfricanAmerican |
3.642900E-03 |
Normal-vs-Asian |
3.873400E-01 |
Caucasian-vs-AfricanAmerican |
2.159400E-01 |
Caucasian-vs-Asian |
2.260000E-01 |
AfricanAmerican-vs-Asian |
5.443200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.5347004757067E-10 |
Normal-vs-Female |
2.01449999999159E-05 |
Male-vs-Female |
6.210200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.584700E-03 |
Normal-vs-Age(41-60Yrs) |
2.85060000049242E-07 |
Normal-vs-Age(61-80Yrs) |
3.86220000425652E-09 |
Normal-vs-Age(81-100Yrs) |
7.54909999955977E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.275000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.856800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.073970E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.851800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.453800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.718830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
7.799400E-01 |
Normal-vs-Grade 2 |
4.620100000019E-06 |
Normal-vs-Grade 3 |
9.35279964586755E-10 |
Normal-vs-Grade 4 |
3.19809734250498E-11 |
Grade 1-vs-Grade 2 |
9.722100E-02 |
Grade 1-vs-Grade 3 |
1.552420E-02 |
Grade 1-vs-Grade 4 |
8.841600E-04 |
Grade 2-vs-Grade 3 |
2.074100E-02 |
Grade 2-vs-Grade 4 |
1.118100E-03 |
Grade 3-vs-Grade 4 |
1.020630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.58925999999004E-05 |
Normal-vs-ccB subtype |
1.86889999997941E-06 |
ccA subtype-vs-ccB subtype |
5.555800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.46200000281394E-08 |
Normal-vs-N1 |
8.499400E-03 |
N0-vs-N1 |
9.103200E-01 |
|
|